Loeb & Loeb LLP is proud to sponsor the Pharmaceutical and Biotechnology Patent Life Cycles and Portfolio Strategies Conference where partner Mark Waddell will be speaking.
From the conference website:
For over a decade, American Conference Institute’s (ACI’s) Maximizing Pharmaceutical Patent Life Cycles and Biotech Patents conferences have brought you up-to –the minute legal, regulatory, and policy information concerning small and large molecule drug products. In re-examining these events, we have determined that just as the pharmaceutical and biotechnology industries have evolved and are now on converging paths that these conferences should also undergo a similar metamorphosis. ACI proudly presents this new program on Pharmaceutical and Biotechnology Patent Life Cycles and Portfolio Strategies.
This conference will give you a comprehensive and thorough picture of how small and large molecule products—as well as diagnostics—operate in a world not only governed by PTO and FDA-related laws and regulations, but also against the backdrop of Hatch-Waxman, BPCIA, iconoclast Supreme Court decisions affecting the future life sciences IP, and Health Care Reform. Our stellar faculty will provide you with insights and strategies relative to life cycle management, portfolio strategies, brand optimization and new product development as well as the in-depth analysis that you have come to expect from ACI’s industry-leading life sciences IP conferences.
From the conference website:
For over a decade, American Conference Institute’s (ACI’s) Maximizing Pharmaceutical Patent Life Cycles and Biotech Patents conferences have brought you up-to –the minute legal, regulatory, and policy information concerning small and large molecule drug products. In re-examining these events, we have determined that just as the pharmaceutical and biotechnology industries have evolved and are now on converging paths that these conferences should also undergo a similar metamorphosis. ACI proudly presents this new program on Pharmaceutical and Biotechnology Patent Life Cycles and Portfolio Strategies.
This conference will give you a comprehensive and thorough picture of how small and large molecule products—as well as diagnostics—operate in a world not only governed by PTO and FDA-related laws and regulations, but also against the backdrop of Hatch-Waxman, BPCIA, iconoclast Supreme Court decisions affecting the future life sciences IP, and Health Care Reform. Our stellar faculty will provide you with insights and strategies relative to life cycle management, portfolio strategies, brand optimization and new product development as well as the in-depth analysis that you have come to expect from ACI’s industry-leading life sciences IP conferences.
-
Co-Chair, Life Sciences; Chair, Patent Litigation & Counseling